Concepedia

Publication | Open Access

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma

10

Citations

49

References

2024

Year

References

YearCitations

2020

2.5K

2009

1.5K

2011

1.5K

2018

1.5K

2017

1.4K

2009

1.2K

1999

750

2008

714

2012

579

2022

556

Page 1